Societal Preferences for Meningococcal B Vaccination in Children: A Discrete Choice Experiment in Spain
Ver/ Abrir
Impacto
Scholar |
Otros documentos de la autoría: Martinon-Torres, Federico; GIL DE MIGUEL, ANGEL; RUIZ-CONTRERAS, JESUS; Vallejo-Aparicio, Laura Amanda; García, Andrea; Gonzalez-Inchausti, María C.; de Gomensoro, Eduardo; Kocaata, Zeki; Gabás Rivera, Clara; Comellas, Marta; Prades, Miriam; Lizán, Luis
Metadatos
Mostrar el registro completo del ítemcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/36080
comunitat-uji-handle3:10234/36082
comunitat-uji-handle4:
INVESTIGACIONMetadatos
Título
Societal Preferences for Meningococcal B Vaccination in Children: A Discrete Choice Experiment in SpainAutoría
Fecha de publicación
2022-11-11Editor
SpringerCita bibliográfica
Martinón-Torres, F., de Miguel, Á.G., Ruiz-Contreras, J. et al. Societal Preferences for Meningococcal B Vaccination in Children: A Discrete Choice Experiment in Spain. Infect Dis Ther 12, 157–175 (2023). https://doi.org/10.1007/s40121-022-00708-7Tipo de documento
info:eu-repo/semantics/articleVersión
info:eu-repo/semantics/publishedVersionPalabras clave / Materias
Resumen
Introduction
Immunization is the most effective strategy for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B (MenB); however, parents need to weigh the risk–benefit and ... [+]
Introduction
Immunization is the most effective strategy for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B (MenB); however, parents need to weigh the risk–benefit and financial impact of immunizing their children against MenB in the absence of a national immunization program (NIP). This study aimed to explore societal preferences (of parents and pediatricians) regarding the attributes of a MenB vaccine in Spain.
Methods
A discrete choice experiment (DCE) based on cross-sectional surveys was carried out to determine preferences. A literature review and scientific committee determined the six attributes related to the MenB vaccine included in the DCE: vaccination age, cost, duration, percentage of protection, adverse events probability, and expert/authority recommendation. Data were analyzed using a mixed logit model. Relative importance (RI) of attributes was calculated and compared between parents and pediatricians.
Results
A total of 278 parents [55.8% female, mean age 40.4 (standard deviation, SD 7.3) years] and 200 pediatricians [73.0% female, mean age 45.8 (SD 12.9) years] answered the DCE. For parents, the highest RI was attributed to vaccine cost, expert/authority recommendation, and percentage of protection (26.4%, 26.1%, and 22.9%, respectively), while for pediatricians the highest RI was assigned to percentage of protection, expert/authority recommendation, and vaccination age (27.2%, 23.7%, and 22.6%, respectively). Significant differences between parents and pediatricians were found in the RI assigned to all attributes (p < 0.001), except for vaccine recommendation.
Conclusion
In the decision regarding MenB vaccination, cost was a driver in parental decision-making but had a low RI for pediatricians and, conversely, vaccination age was highly valued by pediatricians but was the attribute with least importance for parents. Despite these differences, expert/authority recommendation and percentage of protection were essential criteria for both groups. These results provide relevant information about MenB vaccination, highlighting the importance of considering societal preferences for NIP inclusion. [-]
Entidad financiadora
GlaxoSmithKline Biologicals SA
Código del proyecto o subvención
VEO-000341
Derechos de acceso
© GSK 2022
info:eu-repo/semantics/openAccess
info:eu-repo/semantics/openAccess
Aparece en las colecciones
- MED_Articles [639]